KEY TAKEAWAYS Novo Nordisk’s U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for…
Read More »Weightloss
The nonpartisan Congressional Budget Office projected that thanks to the negotiations, Medicare’s prices for semaglutide products “will fall substantially beginning…
Read More »Topline Tesla chief Elon Musk dubbed himself “Ozempic Santa” in an X post on Christmas Day, marking the tech billionaire’s…
Read More »Key Takeaways Eli Lilly’s Zepbound has been approved by the Food and Drug Administration (FDA) as a treatment for adults…
Read More »A few years ago, West Virginia, which has the highest obesity rate in the nation, quietly began a small and…
Read More »The CDC’s recent findings come from a long-running survey known as the National Health and Nutrition Examination Survey, or NHANES,…
Read More »Key Takeaways Eli Lilly and Novo Nordisk shares rose Tuesday after the Biden administration proposed expanding coverage of the companies’…
Read More »Weight-loss and diabetes drug tirzepatide can reduce the risk of death or worsening heart failure for patients with heart failure,…
Read More »It’s unclear how widely the pharmacy’s drugs were distributed. Fullerton Wellness could not be reached for comment. Bigger battles This…
Read More »Young people with severe obesity who underwent weight-loss surgery at age 19 or younger continued to see sustained weight loss…
Read More »